FMP

FMP

Enter

CSTL - Castle Bioscien...

photo-url-https://financialmodelingprep.com/image-stock/CSTL.png

Castle Biosciences, Inc.

CSTL

NASDAQ

Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer; DecisionDx-SCC, a proprietary 40-gene expression profile test that uses an individual patient's tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk factors; and DecisionDx DiffDx-Melanoma and myPath Melanoma, a proprietary GEP test to diagnose suspicious pigmented lesions. It offers test services through physicians and their patients. The company was founded in 2007 and is headquartered in Friendswood, Texas.

29.35 USD

0.93 (3.17%)

About

ceo

Mr. Derek J. Maetzold

sector

Healthcare

industry

Medical - Diagnostics & Research

exchange

NASDAQ

Description

Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer; DecisionDx-SCC, a proprietary 40-gene expression profile test that uses an individual patient's tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk f...

CIK

0001447362

ISIN

US14843C1053

CUSIP

14843C105

Address

505 South Friendswood Drive

Phone

866 788 9007

Country

US

Employee

703

IPO Date

Jul 25, 2019

CSTL Financial Summary

CIK

0001447362

Exchange

NASDAQ

Industry

Medical - Diagnostic...

Sector

Healthcare

CUSIP

14843C105

ISIN

US14843C1053

Country

US

Price

29.35

Beta

1.03

Volume Avg.

414.96k

Market Cap

814.08M

Shares

-

52-Week

12.07-32.53

DCF

33.88

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-244.58

P/B

-

Website

https://castlebiosciences.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest CSTL News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep